Correlation Between Green World and Synmosa Biopharma

Can any of the company-specific risk be diversified away by investing in both Green World and Synmosa Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Green World and Synmosa Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Green World Fintech and Synmosa Biopharma, you can compare the effects of market volatilities on Green World and Synmosa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Green World with a short position of Synmosa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Green World and Synmosa Biopharma.

Diversification Opportunities for Green World and Synmosa Biopharma

-0.51

Correlation Coefficient

Green World  Synmosa Biopharma

Excellent diversification

The 3 months correlation between Green and Synmosa is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Green World Fintech and Synmosa Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synmosa Biopharma and Green World is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Green World Fintech are associated (or correlated) with Synmosa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synmosa Biopharma has no effect on the direction of Green World i.e., Green World and Synmosa Biopharma go up and down completely randomly.

Pair Corralation between Green World and Synmosa Biopharma

Assuming the 90 days trading horizon Green World Fintech is expected to generate 6.09 times more return on investment than Synmosa Biopharma. However, Green World is 6.09 times more volatile than Synmosa Biopharma. It trades about 0.17 of its potential returns per unit of risk. Synmosa Biopharma is currently generating about -0.25 per unit of risk. If you would invest  4,590  in Green World Fintech on September 12, 2024 and sell it today you would earn a total of  2,280  from holding Green World Fintech or generate 49.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Green World Fintech  vs.  Synmosa Biopharma

Green World Fintech

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Green World Fintech are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Green World showed solid returns over the last few months and may actually be approaching a breakup point.

Synmosa Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Synmosa Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Green World and Synmosa Biopharma

The main advantage of trading using opposite Green World and Synmosa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Green World position performs unexpectedly, Synmosa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synmosa Biopharma will offset losses from the drop in Synmosa Biopharma's long position.

The idea behind Green World Fintech and Synmosa Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.